Danaher Corporation

DHR

US2358511028

Advanced Medical Equipment & Technology

Market Closed - Nyse Other stock markets 01:30:02 14/09/2024 am IST			5-day change	1st Jan Change
274.25 ^USD	+0.65%		+3.02%	+18.55%

13/09	RBC Raises Price Target on Danaher to $333 From $300, Keeps Outperform Rating	MT
11/09	Analyst recommendations: Exxon Mobil, Accenture, Citigroup, Morgan Stanley...

This article is reserved for members

To unlock the article, REGISTER!

100% Free Registration

Already a customer? Log In

Latest news about Danaher Corporation

RBC Raises Price Target on Danaher to $333 From $300, Keeps Outperform Rating	13/09	MT
Analyst recommendations: Exxon Mobil, Accenture, Citigroup, Morgan Stanley...	11/09
Deutsche Bank Raises Price Target on Danaher to $285 From $270	11/09	MT
Danaher Keeps Quarterly Dividend at $0.27 a Share, Payable Oct. 25 to Shareholders of Record Sept. 27	11/09	MT
Transcript : Danaher Corporation - Analyst/Investor Day	05/09
Danaher Reiterates Q3, Full Year 2024 Guidance	05/09	MT
Wells Fargo Initiates Danaher at Equalweight With $280 Price Target	28/08	MT
Danaher Corp Insider Sold Shares Worth $255,483, According to a Recent SEC Filing	28/08	MT
Danaher Corporation acquired Genedata AG.	19/08	CI
From Mammograms to Molecules: Hologic's Quest in Women's Health Tech	31/07
Danaher Insider Sold Shares Worth $3,924,352, According to a Recent SEC Filing	29/07	MT
Redburn Atlantic Adjusts Price Target on Danaher to $280 From $260	25/07	MT
TD Cowen Adjusts Price Target on Danaher to $310 From $290	24/07	MT
HSBC Adjusts Price Target on Danaher to $300 From $290	24/07	MT
Baird Adjusts Price Target on Danaher to $278 From $275	24/07	MT
Leerink Adjusts Price Target on Danaher to $280 From $275	24/07	MT
Barclays Adjusts Price Target on Danaher to $285 From $270	24/07	MT
Raymond James Adjusts Price Target on Danaher to $310 From $285	24/07	MT
Stifel Adjusts Price Target on Danaher to $250 From $235	24/07	MT
Citigroup Adjusts Price Target on Danaher to $305 From $290	24/07	MT
JPMorgan Adjusts Price Target on Danaher to $305 From $295	24/07	MT
RBC Raises Price Target on Danaher to $300 From $297, Keeps Outperform Rating	24/07	MT
Thermo Fisher lifts profit forecast as biotech demand shows signs of improvement	24/07	RE
Goldman Sachs Raises Danaher's Price Target to $250 From $225	23/07	MT
Top Midday Stories: GM Beats Earnings Estimates, But Stock Down on Electric Truck Factory Delay; Coca-Cola, GE Shares Up on Earnings Beats; Comcast, UPS Shares Down on Earnings Misses	23/07	MT

Danaher Corporation is an industrial and technologic group organized around two families of products: - medical equipment (70.1% of net sales): diagnostic equipment, digital imaging systems, optical instruments, microscopes, consumables, etc.; - professional instruments of analysis (29.9%): systems of quality control of waters, disinfection, etc. Net sales are distributed geographically as follows: the United States (40.1%), China (13.2%) and other (46.7%).

Employees

62,000

Sector

Advanced Medical Equipment & Technology

Calendar

17/10/2024 - Q3 2024 Earnings Release (Projected)

More about the company